(1)

The maximum residue limit for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry should be established in accordance with Regulation (EC) No 470/2009.

(2)

Pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin are set out in the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (2).

(3)

Phenoxymethylpenicillin is currently included in Table 1 of the Annex to Regulation (EU) No 37/2010 as an allowed substance, for porcine species, applicable to muscle, liver and kidney and for poultry species, applicable to muscle, skin and fat, liver and kidney, excluding animals from which eggs are produced for human consumption.

(4)

An application for the extension of the existing entry for phenoxymethylpenicillin to include eggs for poultry species has been submitted to the European Medicines Agency.

(5)

The Committee for Medicinal Products for Veterinary Use has recommended establishing a maximum residue limit (hereinafter ‘MRL’) for phenoxymethylpenicillin for porcine species, applicable to muscle, liver and kidney and for poultry species, applicable to muscle, skin and fat, liver, kidney and eggs.

(6)

The entry for phenoxymethylpenicillin in Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended to include the MRL for eggs for poultry species.

(7)

It is appropriate to provide for a reasonable period of time for the stakeholders concerned to take measures that may be required to comply with the newly set MRL.

(8)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

(1)

The maximum residue limit for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry should be established in accordance with Regulation (EC) No 470/2009.

(2)

Pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin are set out in the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (2).

(3)

Altrenogest is currently included in Table 1 of the Annex to Regulation (EU) No 37/2010 as an allowed substance, for porcine species, applicable to skin, fat and liver and to equidae species, applicable to fat and liver.

(4)

An application for the modification of the existing entry for altrenogest has been submitted to the European Medicines Agency.

(5)

Additional data were provided and assessed leading the Committee for Medicinal Products for Veterinary Use to recommend the modification of the current MRLs for altrenogest.

(6)

The entry for altrenogest in Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended accordingly.

(7)

It is appropriate to provide for a reasonable period of time for the stakeholders concerned to take measures that may be required to comply with the newly set MRL.

(8)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

(1)

The maximum residue limit (‧MRL‧) for pharmacologically active substances intended for use in the Union in veterinary medicinal products for food-producing animals or in biocidal products used in animal husbandry should be established in accordance with Regulation (EC) No 470/2009.

(2)

Pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin are set out in the Annex to Commission Regulation (EU) No 37/2010 of 22 December 2009 on pharmacologically active substances and their classification regarding maximum residue limits in foodstuffs of animal origin (2).

(3)

Lasalocid is currently included in Table 1 of the Annex to Regulation (EU) No 37/2010 as an allowed substance for poultry species, applicable to muscle, skin and fat, liver, kidney and eggs.

(4)

An application for the extension of the existing entry to include bovine species has been submitted to the European Medicines Agency.

(5)

The Committee for Medicinal Products for Veterinary Use has recommended the extension of that entry to cover bovine species, applicable to muscle, fat, liver and kidney, excluding animals producing milk for human consumption.

(6)

The entry for lasalocid in Table 1 of the Annex to Regulation (EU) No 37/2010 should therefore be amended to include bovine species.

(7)

It is appropriate to provide for a reasonable period of time for the stakeholders concerned to take measures that may be required to comply with the newly set MRL.

(8)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on Veterinary Medicinal Products,

(1)

By Commission Directive 2011/21/EU (2) clethodim was included as active substance in Annex I to Directive 91/414/EEC for uses as herbicide on sugar beet. Since the replacement of Directive 91/414/EEC by Regulation (EC) No 1107/2009, this substance is deemed to have been approved under that Regulation and is listed in Part A of the Annex to Commission Implementing Regulation (EU) No 540/2011 of 25 May 2011 implementing Regulation (EC) No 1107/2009 of the European Parliament and of the Council as regards the list of approved active substances (3).

(2)

On 14 February 2011 Arysta LifeScience, at whose request clethodim was included in Annex I to Directive 91/414/EEC, submitted an application for an amendment to the conditions of inclusion of clethodim to allow its use as a herbicide on crops other than sugar beet. That application was accompanied by additional information. It was submitted to the Netherlands, which had been designated rapporteur Member State by Commission Regulation (EC) No 1490/2002 (4).

(3)

The Netherlands evaluated the additional information submitted by the applicant and prepared an addendum to the draft assessment report. It submitted that addendum to the Commission on 28 March 2011. The Netherlands communicated the addendum to the other Member States and to the European Food Safety Authority (hereinafter ‘the Authority’) for comments and forwarded the comments received to the Commission.

(4)

The Authority organised a consultation of experts on the addendum to the draft assessment report. On 15 October 2011 the Authority communicated its conclusion to the applicant, the Member States and the Commission and made it available to the public. Taking into account the comments received from the applicant, the Authority modified its conclusion. It submitted its modified conclusion to the applicant, the Member States and the Commission and made it available to the public on 18 November 2011 (5).

(5)

In accordance with Article 13(1) of Regulation (EC) No 1107/2009 the Commission invited the applicant to submit its comments on the review report for clethodim. The notifier submitted its comments, which have been carefully examined.

(6)

The addendum to the draft assessment report and the conclusion of the Authority were reviewed by the Member States and the Commission within the Standing Committee on the Food Chain and Animal Health and were finalised on 9 December 2011 in the format of the Commission review report for clethodim.

(7)

It has appeared from the various examinations carried out that the restriction to sugar beets of the use of plant protection products consisting of or containing clethodim may be lifted.

(8)

The Annex to Implementing Regulation (EU) No 540/2011 should therefore be amended accordingly.

(9)

The measures provided for in this Regulation are in accordance with the opinion of the Standing Committee on the Food Chain and Animal Health,

(1)

Annex IV to Regulation (EC) No 1210/2003 lists the natural and legal persons, bodies or entities associated with the regime of former President Saddam Hussein covered by the freezing of funds and economic resources under that Regulation.

(2)

On 2 June 2011, the Sanctions Committee of the United Nations Security Council decided to remove two natural persons from the list of persons or entities to whom the freezing of funds and economic resources should apply, with reference to paragraph 23(b) of Resolution 1483(2003) of the United Nations Security Council. Furthermore, on 6 December 2011 the Sanctions Committee decided to remove one natural person from this list.

(3)

Annex V to Regulation (EC) No 1210/2003 lists the competent authorities to which specific functions relating to the implementation of that Regulation are attributed. This list should be updated on the basis of information received from Greece and Hungary.

(4)

Annexes IV and V to Regulation (EC) No 1210/2003 should therefore be amended accordingly.

(1)

Implementing Regulation (EU) No 543/2011 lays down, pursuant to the outcome of the Uruguay Round multilateral trade negotiations, the criteria whereby the Commission fixes the standard values for imports from third countries, in respect of the products and periods stipulated in Annex XVI, Part A thereto.

(2)

The standard import value is calculated each working day, in accordance with Article 136(1) of Implementing Regulation (EU) No 543/2011, taking into account variable daily data. Therefore this Regulation should enter into force on the day of its publication in the Official Journal of the European Union,

(1)

According to the Protocol on Transitional Provisions annexed to the Treaty on European Union, to the Treaty on the Functioning of the European Union and to the Treaty establishing the European Atomic Energy Community, the legal effects of the acts of the institutions, bodies, offices and agencies of the Union adopted prior to the entry into force of the Treaty of Lisbon are preserved until those acts are repealed, annulled or amended in implementation of the Treaties.

(2)

Accordingly, Article 25 of Decision 2008/615/JHA is applicable and the Council must unanimously decide whether the Member States have implemented the provisions of Chapter 6 of that Decision.

(3)

Article 20 of Decision 2008/616/JHA provides that decisions referred to in Article 25(2) of Decision 2008/615/JHA are to be taken on the basis of an evaluation report based on a questionnaire. With respect to automated data exchange in accordance with Chapter 2 of Decision 2008/615/JHA, the evaluation report is to be based on an evaluation visit and a pilot run.

(4)

The Czech Republic has informed the General Secretariat of the Council of the national DNA analysis files to which Articles 2 to 6 of Decision 2008/615/JHA apply and the conditions for automated searching as referred to in Article 3(1) of that Decision in accordance with Article 36(2) of that Decision.

(5)

According to Chapter 4, point 1.1, of the Annex to Decision 2008/616/JHA, the questionnaire drawn up by the relevant Council Working Group concerns each of the automated data exchanges and has to be answered by a Member State as soon as it believes it fulfils the prerequisites for sharing data in the relevant data category.

(6)

The Czech Republic has completed the questionnaire on data protection and the questionnaire on DNA data exchange.

(7)

A successful pilot run has been carried out by the Czech Republic with Slovakia.

(8)

An evaluation visit has taken place in the Czech Republic and a report on the evaluation visit has been produced by the Slovakian evaluation team and forwarded to the relevant Council Working Group.

(9)

An overall evaluation report, summarising the results of the questionnaire, the evaluation visit and the pilot run concerning DNA data exchange has been presented to the Council,

(1)

On 16 March 2009, the Council adopted Decision 2009/250/EC (2) appointing three members of the European Statistical Governance Advisory Board (‘the Board’) for a period of 3 years from 23 March 2009.

(2)

It is therefore necessary to appoint three new members to take office upon expiry of the terms of office which began on 23 March 2009.

(3)

According to Article 3(2) in Decision No 235/2008/EC, the members of the Board are to be selected from among experts possessing outstanding competence in the field of statistics,

Mr Günter KOPSCH,

Ms Pilar MARTÍN-GUZMÁN,

Mr Edvard OUTRATA.

(1)

The terms of office of Mr Olavi ALA-NISSILÄ, Mr Vítor Manuel da SILVA CALDEIRA, Mr Morten Louis LEVYSOHN, Mr Eoin O’SHEA, Mr Karel PINXTEN, Mr Massimo VARI and Mr H.G. WESSBERG are due to expire on 29 February 2012.

(2)

New appointments should therefore be made,

—

Mr Kevin CARDIFF,

—

Mr Vítor Manuel da SILVA CALDEIRA,

—

Mr Ville ITÄLÄ,

—

Mr Henrik OTBO,

—

Mr Karel PINXTEN,

—

Mr Pietro RUSSO,

—

Mr H.G. WESSBERG,

(1)

The accounts of the European Central Bank (ECB) and of the national central banks of the Eurosystem are to be audited by independent external auditors recommended by the Governing Council of the ECB and approved by the Council of the European Union.

(2)

The mandate of the current external auditors of De Nederlandsche Bank ended after the audit for the financial year of 2011. It is therefore necessary to appoint external auditors from the financial year 2012.

(3)

De Nederlandsche Bank has selected Deloitte Accountants BV as its external auditors for the financial years 2012 to 2018.

(4)

The Governing Council of the ECB recommended that Deloitte Accountants BV be appointed as the external auditors of De Nederlandsche Bank for the financial years 2012 to 2018.

(5)

It is appropriate to follow the recommendation of the Governing Council of the ECB and to amend Council Decision 1999/70/EC (2) accordingly,

(1)

On 22 December 2009 and on 18 January 2010, the Council adopted Decisions 2009/1014/EU (1) and 2010/29/EU (2) appointing the members and alternate members of the Committee of the Regions for the period from 26 January 2010 to 25 January 2015.

(2)

An alternate member’s seat has become vacant following the end of the term of office of Mr Jordi BAYONA LLOPIS,

—

Mr Esteban MAS PORTELL, Delegado del Gobierno de las Illes Balears en Bruselas.